about
Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell ResponsesAn Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 QuasispeciesMicroarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment.Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep.Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppressionOvine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.Lethal mutagenesis of viruses.Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV.A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice.IL-10: A Multifunctional Cytokine in Viral Infections.Ribavirin can be mutagenic for arenaviruses.No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus.Viral fitness can influence the repertoire of virus variants selected by antibodies.Monitoring sequence space as a test for the target of selection in viruses.Establishment of a Zebrafish Infection Model for the Study of Wild-Type and Recombinant European Sheatfish Virus.Mutagenesis-mediated virus extinction: virus-dependent effect of viral load on sensitivity to lethal defection.Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.Influence of the mutant spectrum in viral evolution: focused selection of antigenic variants in a reconstructed viral quasispecies.Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy.An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis.Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.Successful use of a plant gene in the treatment of cancer in vivo.Reverse Genetic Approaches for the Generation of Recombinant Zika Virus
P50
Q27340815-7B7101D2-2873-40DC-B2FA-0FD4A6C2446FQ28554999-148CC09F-7C92-4019-8C38-C247C6363695Q33243910-11D55723-7759-4239-B109-63072D1A65BBQ33889779-5577E472-9954-4A98-9DC0-D31C67387A06Q37346805-7946E1C6-91E3-4A63-A12A-2073DF469F57Q37716789-5458D616-6E99-4F68-9CFD-15B698EB0069Q37996204-BB0C61B1-3563-48E1-B333-75EC194CA008Q38064285-2DE02A9D-B0DD-4537-843D-7DD99E2B426DQ39057140-E55BE81A-CA0F-49ED-9525-2CD4896D1196Q39063204-40330CB7-D2B2-4B84-BEB0-5027A02F172CQ39186731-09291262-D7B6-49D6-96AD-C86F69E34919Q39544616-2A31B20A-925B-4DEF-BB84-440320EF7A86Q39969343-CF81B145-E78C-48DC-AB61-2F6E5298E09BQ40246963-D54CBE3A-4838-4AC4-8D51-D82051682B8DQ40484286-850A0BDE-1E70-4C4A-8B21-685E05AD1674Q40655765-477D55EA-5CE3-4E00-A51D-32ED868D65B6Q41896864-7413A373-6552-4F52-8713-D7E0D94C79C5Q41909022-E05CE7D8-7842-4739-A115-AD45AF5B1C29Q42696074-8D832C98-2E7E-4846-AA11-DD84D04ADFB1Q42812515-C79E11C4-EE14-4370-AA9E-C84B69DE843EQ43223379-DF1E21B4-713D-4605-9F6F-40C9EB29A372Q45324559-83C84DB6-9703-4138-B2DA-703553DA15A0Q45855906-1D3ED20D-6C38-434E-8D10-66922881318DQ58588686-8091F238-7A84-4144-BD50-7D34368B1E7C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Verónica Martín
@ast
Verónica Martín
@en
Verónica Martín
@es
Verónica Martín
@nl
Verónica Martín
@sl
type
label
Verónica Martín
@ast
Verónica Martín
@en
Verónica Martín
@es
Verónica Martín
@nl
Verónica Martín
@sl
prefLabel
Verónica Martín
@ast
Verónica Martín
@en
Verónica Martín
@es
Verónica Martín
@nl
Verónica Martín
@sl
P1053
H-2776-2015
P106
P21
P31
P3829
P496
0000-0003-1486-1656